Detalhe da pesquisa
1.
Non-randomized evaluation of hospitalization after a prescription for nirmatrelvir/ritonavir versus molnupiravir in high-risk COVID-19 outpatients.
J Antimicrob Chemother
; 78(7): 1683-1688, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37229547
2.
Assessment of unvaccinated and vaccinated patients with coronavirus disease 2019 (COVID-19) treated with monoclonal antibodies during the delta wave (July 1-August 20, 2021): a retrospective observational monocentric study.
BMC Infect Dis
; 22(1): 645, 2022 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35896965